Antonio Gallardo-Pizarro Profile
Antonio Gallardo-Pizarro

@agallardop_

Followers
14
Following
8
Statuses
52

Barcelona, España
Joined April 2024
Don't wanna be here? Send us removal request.
@agallardop_
Antonio Gallardo-Pizarro
10 days
RT @gemicomed: #DíamundialdelaAspergilosis 🍄 La resistencia a azoles en A. fumigatus es un fenómeno emergente que tiene consecuencias direc…
0
9
0
@agallardop_
Antonio Gallardo-Pizarro
13 days
RT @antecesorcomun: Es muy importante no usar Deepseek, que vulnera todo tipo de normas de seguridad y privacidad de datos y en su lugar us…
0
5K
0
@agallardop_
Antonio Gallardo-Pizarro
15 days
RT @infeccHRUmalaga: En #MIR2025 la 2️⃣ materia más preguntada: #EnfermedadesInfecciosas solo detrás de #Cardiologia 📸👇🏻, curioso🤔 q siendo…
0
32
0
@agallardop_
Antonio Gallardo-Pizarro
25 days
RT @drtimothyli: Summary of new antibiotic agents for the treatment of MDR Gram negative bacterial infections htt…
0
233
0
@agallardop_
Antonio Gallardo-Pizarro
1 month
RT @c_garciavidal: Hola todos, pero + a los R5 de M Interna 😊! Buscamos médicos para hacer tesis doctoral en infecciones en inmunodeprimido…
0
16
0
@agallardop_
Antonio Gallardo-Pizarro
1 month
RT @err_wallace: Doing a PhD is hard, but never underestimate the value of doing work that you are passionate about, to feel seen and heard…
0
287
0
@agallardop_
Antonio Gallardo-Pizarro
1 month
0
8
0
@agallardop_
Antonio Gallardo-Pizarro
1 month
RT @c_garciavidal: Very excited to start 2025 with this important publication! @hospitalclinic @idibaps Once again, we demonstrate that #…
0
12
0
@agallardop_
Antonio Gallardo-Pizarro
1 month
💬 Clinical Decision-Making: How do you see machine learning shaping decisions in managing infections for patients with hematological malignancies? Let’s discuss! (6/6) #MachineLearning #AntibioticStewardship #InfectiousDiseases #PrecisionMedicine #Hematology #FebrileNeutropenia
0
0
0
@agallardop_
Antonio Gallardo-Pizarro
1 month
💡 The Challenge Multidrug-resistant infections demand personalized antibiotic strategies for febrile neutropenia in hematological malignancies. Despite guideline-based therapies, the growing burden of resistance exposes critical gaps in effective management. (2/6)
0
0
1
@agallardop_
Antonio Gallardo-Pizarro
2 months
Treating Patients, Not P Values | NEJM Evidence
0
0
0
@agallardop_
Antonio Gallardo-Pizarro
2 months
RT @hospitalclinic: 🏅El Dr. Josep Maria Miró, consultor Sénior del Servicio de Enfermedades Infecciosas del #CLÍNIC, ha sido escogido acadé…
0
6
0
@agallardop_
Antonio Gallardo-Pizarro
2 months
RT @ABsteward: I remember this photo each time I see Stenotrophomonas maltophilia sneaking somewhere while the patient is receiving meropen…
0
7
0
@agallardop_
Antonio Gallardo-Pizarro
3 months
RT @hospitalclinic: @ticsalut @MITCriticalData @idibaps @salutcat @BSC_CNS @mitspain 🚀 Barcelona acoge la primera edición del #GenAIHealthH
0
1
0